Will the Phase 2 trial "Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate." reach primary completion on or before Apr 17, 2028?

Resolves Yes if ClinicalTrials.gov record NCT06408337 (Elisa María Cubiles Montero de Espinosa) shows an actual primary completion date on or before Apr 17, 2028. Registered date at generation: Apr 17, 2028.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Apr 17, 2028, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.